002349.SZ
Jinghua Pharmaceutical Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 6.81
−1.59%Year over year
Reported trailing growth
- Revenue
- +5.6%
- EBITDA
- —
- EBIT
- +12.0%
- EPS
- +9.1%
- Free cash flow
- -8.1%
- Operating cash flow
- -7.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.5%
- EBITDA
- +1.9%
- EBIT
- +6.6%
- Net income
- +1.1%
- EPS
- +0.9%
- Free cash flow
- +2.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026